1. Home
  2. OVLY vs GOSS Comparison

OVLY vs GOSS Comparison

Compare OVLY & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oak Valley Bancorp (CA)

OVLY

Oak Valley Bancorp (CA)

HOLD

Current Price

$30.50

Market Cap

242.9M

Sector

Finance

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.67

Market Cap

726.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OVLY
GOSS
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.9M
726.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
OVLY
GOSS
Price
$30.50
$3.67
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.60
AVG Volume (30 Days)
13.1K
2.9M
Earning Date
01-23-2026
11-05-2025
Dividend Yield
1.99%
N/A
EPS Growth
N/A
N/A
EPS
2.84
N/A
Revenue
$79,783,000.00
$44,051,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.41
P/E Ratio
$10.61
N/A
Revenue Growth
2.98
N/A
52 Week Low
$22.70
$0.76
52 Week High
$32.24
$3.80

Technical Indicators

Market Signals
Indicator
OVLY
GOSS
Relative Strength Index (RSI) 69.24 69.66
Support Level $27.66 $3.34
Resistance Level $28.25 $3.80
Average True Range (ATR) 0.50 0.20
MACD 0.22 0.02
Stochastic Oscillator 96.54 83.64

Price Performance

Historical Comparison
OVLY
GOSS

About OVLY Oak Valley Bancorp (CA)

Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: